Results for pharmaceuticals: 2165

* Hep B drugs have blockbuster potential * $24.5 bln market to possibly triple by 2013 (Recasts, adds details on priority drug list) NEW YORK, July 22 - China's $124 billion plan to provide basic...

* Hep B, hypertension drugs have blockbuster potential * $24.5 bln market to possibly triple by 2013 NEW YORK, July 22 - China's ambitious $124 billion effort to provide basic health coverage for the vast...

This article from our sister site, ControlDesign.com, spotlights a machine builder's monoblock servo bottle filler/capper motion control system that uses four...

Chongqing Lummy Pharmaceutical Co Ltd<300006>, a Chongqing-based bio-pharmaceutical firm, debuted on the ChiNext Board on the Shenzhen Stock Exchange today, and its shares skyrocket 116.97% above the IPO price on its first day of trading.Shares of the company started trading at RMB 27.45, a price...

Tianjin Chase Sun Pharmaceutical Co Ltd<300026> debuted on the ChiNext Board on the Shenzhen Stock Exchange today, and its shares surged 77.5% above its IPO price on its first day of trading. Shares of the company started trading at RMB 97.15, a price 61.92% higher than the issue price. They...

Beijing Beilu Pharmaceutical Co Ltd<300016>, which is mainly engaged in the manufacture and sale of pharmaceuticals, with focus on traditional Chinese medicines, debuted on the ChiNext Board on the Shenzhen Stock Exchange today, and its shares jumped 99.33% above the IPO price on its first day of...

Sanofi-Aventis, the fourth-largest pharmaceutical company by prescription sales, Saturday signed a letter of intent with China's Minsheng Pharmaceutical Group on setting up a joint venture that focuses on vitamin and mineral medicines. The new JV will be a strategic platform for Sanofi-Aventis to enter the Chinese...

Shanghai Fosun Pharmaceutical (Group) Co Ltd<600196> said on Tuesday that its net profit attributable to parent company will reach RMB 2.13 billion in the first three quarters of this year.The figure reflects a surge of more than 250% compared with the RMB 609 million earned in the same period of last year, said the...

Baring Asset Management Ltd, a global investment management firm, on Tuesday cut its H share holding in Guangzhou Pharmaceutical Co Ltd<600332><0874> to 5.6% from the previous 6.06%, according to the bourse operator Hong Kong Exchanges and Clearing<0388>.HKEx said Baring Asset sold 1.01 million H...

Singapore-listed Sihuan Pharmaceutical Holdings Group Ltd is slated to become a wholly-owned subsidiary of China Pharma Ltd, a joint venture between Morgan Stanley Private Equity Asia and the controlling shareholders of Sihuan Pharmaceutical.China Pharma Ltd on Monday issued a statement...